Ipamorelin 2mg — Vial Spec, Reconstitution Math & COA

Overview of the Ipamorelin 2mg Research Specification

A 2mg vial of Ipamorelin contains exactly 2.0 milligrams of high-purity, lyophilized pentapeptide (Aib-His-D-2Nal-D-Phe-Lys-NH2) combined with a precise quantity of bulking agent (typically mannitol or trehalose) to form a stable, vacuum-sealed cake. Laboratory researchers select the 2mg configuration primarily for short-duration in vitro assays, micro-dose preclinical animal trials, or initial assay validation studies where minimizing reconstituted storage time is critical to maintaining peptide integrity.

In cell culture models and rodent research, Ipamorelin acts as a potent ghrelin receptor agonist with high specificity for the growth hormone secretagogue receptor (GHS-R1a). The 2mg fill mass provides an ideal balance for research teams requiring fresh, fully active working solutions without leaving reconstituted material in liquid storage beyond recommended degradation limits. For complete product specifications and available fill volumes, consult our primary Ipamorelin research powder product page.

Molecular Mechanism and Receptor Selectivity in Preclinical Studies

Ipamorelin is categorized as a selective growth hormone secretagogue (GHS). Preclinical models demonstrate that it binds specifically to GHS-R1a in the anterior pituitary and hypothalamus, triggering a conformational change that activates the phospholipase C (PLC) pathway. This cascade results in intracellular calcium mobilization and the pulsatile release of somatotropes. Unlike earlier generation secretagogues, in vitro and in vivo studies confirm that Ipamorelin does not trigger significant depolarizing cross-reactivity at the receptors responsible for adrenocorticotropic hormone (ACTH) or prolactin release.

Consequently, preclinical assays measuring systemic hormone dynamics following Ipamorelin exposure show distinct GH spikes without corresponding surges in serum cortisol or prolactin. This non-target selectivity makes Ipamorelin a foundational control compound in studies evaluating somatotropic pathways, tissue regeneration models, and metabolic flux analysis across specialized growth hormone secretagogues.

Reconstitution Mathematics for a 2mg Lyophilized Mass

Accurate volumetric reconstitution is necessary to achieve precise working concentrations during micro-pipetting. When working with a 2mg (2,000 micrograms) lyophilized vial, adding different volumes of sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl) yields predictable concentrations.

To perform these calculations seamlessly in the laboratory, researchers frequently utilize our integrated peptide reconstitution calculator. Standard reconstitution ratios for a 2mg vial include:

• 1.0 mL Diluent Volume: Reconstituting 2,000 µg of peptide with 1.0 mL of liquid yields a working concentration of exactly 2.0 µg/µL (or 2000 µg/mL). A micro-pipette volume of 10 µL yields 20 µg of target compound. • 2.0 mL Diluent Volume: Reconstituting 2,000 µg with 2.0 mL of liquid yields a concentration of 1.0 µg/µL (1000 µg/mL). In this configuration, each 10 µL pipette volume contains 10 µg of active peptide. • 3.0 mL Diluent Volume: Adding 3.0 mL of diluent produces a concentration of approximately 0.67 µg/µL (666.67 µg/mL). This lower concentration is frequently selected for high-precision micro-dosing assays where larger liquid delivery volumes reduce volumetric pipetting error margins.

Aliquot Planning and Working Solution Preservation Protocols

Lyophilized peptides exhibit maximum long-term stability when stored unopened at -20°C to -80°C. Once reconstituted with a liquid diluent, the peptide chains become susceptible to hydrolytic cleavage, oxidation, and surface adsorption. To preserve biological activity across multi-day cell culture or animal series, laboratory protocols require strict aliquot management.

Upon reconstitution, the 2mg solution should be sub-aliquoted into single-use micro-centrifuge tubes using low-binding polypropylene vials to prevent protein adherence to container walls. Aliquots intended for use within 7 to 14 days may be held at 2°C to 8°C if reconstituted with bacteriostatic diluents. Stock aliquots slated for longer storage should be immediately snap-frozen in liquid nitrogen and transferred to -80°C. Repeated freeze-thaw cycles must be strictly avoided, as mechanical shear stress during ice crystal formation degrades the secondary structure of the peptide.

Comparative Analysis: Ipamorelin vs. Related GH Secretagogues

When designing comparative secretory assays, investigators often evaluate Ipamorelin alongside structural and functional analogs within the growth hormone secretagogue domain. Below is a target comparison across prominent secretagogues available in our full catalog of research peptides:

Ipamorelin stands out due to its minimal impact on secondary hormonal axes. In comparative rodent assays, while GHRP-2 exhibits high potency for GH release, it simultaneously induces dose-dependent increases in ACTH and cortisol levels. Similarly, Hexarelin demonstrates robust somatotrope activation but is subject to rapid receptor desensitization (tachyphylaxis) upon repeated administration. Conversely, when researchers combine Ipamorelin with long-acting GHRH analogs such as CJC-1295 No DAC, preclinical models show a synergistic amplification of pulsatile growth hormone output due to simultaneous activation of both the ghrelin and GHRH receptor pathways.

Lot-Matched COA, Purity Verification, and Endotoxin Testing

PX1 Research enforces stringent quality control mandates for every manufactured batch of Ipamorelin. Prior to releasing any batch for laboratory distribution, representative samples undergo high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis at an independent, ISO 17025-accredited laboratory.

Every 2mg vial is linked directly to a lot-specific certificate. Researchers can verify chemical identity and purity profiles by accessing our centralized lot-specific Certificate of Analysis database. High-resolution HPLC chromatograms verify a chemical purity profile of ≥99.0%, while mass spectrometry confirms exact molecular mass against theoretical sequence weights. Furthermore, chromogenic LAL assays ensure bacterial endotoxin levels remain below strictly defined limits (<0.01 EU/µg), eliminating confounding inflammatory variables in cell culture and animal models.

Determining Ideal Vial Size: 2mg vs. 5mg or 10mg Formats

Selecting the optimal vial size depends directly on experimental scale, animal cohort size, and assay duration. While PX1 Research maintains high-purity Ipamorelin research powder across multiple mass configurations (including standard 2mg, 5mg, and 10mg vials), matching fill volume to study design prevents unnecessary peptide degradation and material waste.

The 2mg format is ideal for preliminary in vitro work, baseline receptor binding assays, or small rodent pilot studies requiring low total volume over a 5 to 7 day period. For larger scale longitudinal animal studies or multi-center research programs, 5mg or 10mg vials offer enhanced cost efficiencies and reduce lot-to-lot reconstitution overhead. Institutional procurement teams managing high-throughput facilities can access volume pricing structures through the PX1 wholesale account program.

Laboratory Storage, Reconstitution Diluents, and Handling Logistics

To maintain structural integrity, unconstituted 2mg Ipamorelin vials must be stored in a dry, dark environment at -20°C upon receipt. Prior to reconstitution, vials should be allowed to acclimate to room temperature inside a desiccator chamber to prevent moisture condensation on the lyophilized cake.

Reconstitution should be performed using aseptic technique within a certified laminar flow hood. Diluent—whether sterile water for injection, bacteriostatic water, or buffered saline—should be introduced slowly down the internal glass wall of the vial rather than sprayed directly onto the peptide powder. Gentle manual rotation is recommended to complete dissolution; vortexing must be avoided to protect peptide secondary structures. Detailed storage and handling whitepapers are accessible in the PX1 research library.